Reading CCRN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CCRN free→Reading CCRN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CCRN free→
NASDAQHealth CareMedical Care FacilitiesSnapshot 2026-06-15
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and earnings quality cannot be assessed since the company was unprofitable over the past year. Management's recent track record has been unsteady, with frequent disruptive corporate changes. Risk is high, and the sector backdrop is a headwind, although CCRN trades above typical for sector peers. Peer multiples imply a price about 50% above where it trades (it looks cheap on this basis); the read is cheap, value-trap risk, as it trades below peer multiples while recent financials are weak. This analysis is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 2 valuation methods, at three horizons. Current price $13.17. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $13 CCRN trades at 0× p/s, below its 1× p/s peer median. Our $25 fair value sits above the price; low confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 47% below a flat-multiple fair value, below our forecast of about -23%. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Only a turbulent sector regime (Heating) — not the full expensive x weak x turbulent stack.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Health Care names rated weak grew net income 55% of the time over the next year (vs 54% for the rest of the cohort, n=2391).
Over the trailing year it converted -0.48x of net income into operating cash flow.
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, long-term interest rates, Fed net liquidity, real (inflation-adjusted) rates.
8 material management or governance events in the past 24 months, led by executive changes. Historically, Health Care names rated volatile grew net income 43% of the time over the next year (vs 57% for the rest of the cohort, n=600).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.01 → $0.02 (+4.7% / 30d). 0 raised, 1 cut, 7 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 10% of analysts rate Buy.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$88.
How much price usually moves either way.
On a bad day, this stock has moved -$451.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $4,716.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: The earnings report will show if the company can improve its financial performance. Investors will look for signs of recovery.
Confirms one read:The earnings report shows revenue growth speeding up again. This means recovery is happening.
Confirms the other:The earnings report shows revenue still going down. There is no sign of profit improvement.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for CCRN yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition (a) On May 7, 2026, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended March 31, 2026, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Health Care Facilities.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
CCRN Cross Country Healthcare, Inc. | Above typical Show detailsSector percentile: 96 of 100 | inexpensive | high |
HCA HCA Healthcare | Above typical Show detailsSector percentile: 81 of 100 | fair | moderate |
THC Tenet Health | Above typical Show detailsSector percentile: 87 of 100 | fair | elevated |
EHC Encompass Health | Above typical Show detailsSector percentile: 97 of 100 | full | moderate |
UHS Universal Health Services | Above typical Show detailsSector percentile: 93 of 100 | inexpensive | elevated |
Not investment advice. As of 2026-06-15.
via XLV
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
Cross Country Healthcare entered into a merger agreement with KL Criss Cross Intermediate, LLC.
Newly stated in 2026-Q1. Cross Country Healthcare announced a merger agreement with KL Criss Cross Intermediate, LLC. This strategic move is aimed at growth through M&A activity. The financials do not yet reflect the impact of this merger, as it is a recent development.
“Cross Country Healthcare entered into an Agreement and Plan of Merger with KL Criss Cross.”
Management provided revenue guidance for 2026-Q1 between $235 million and $240 million.
Newly stated in 2026-Q1. Management provided revenue guidance for 2026-Q1 between $235 million and $240 million. Actual revenue for 2026-Q1 was $241.057 million, slightly exceeding the guidance range, indicating a positive trajectory.
“Q1 2026 Range Revenue $235 million - $240 million.”
Management provided adjusted EPS guidance for 2026-Q1 between $(0.06) and $(0.04).
Newly stated in 2026-Q1. Management provided adjusted EPS guidance for 2026-Q1 between $(0.06) and $(0.04). The actual diluted EPS for 2026-Q1 was $(0.14), which is below the guidance range, indicating a negative trajectory.
“Adjusted EPS* $(0.06) - $(0.04).”
Why it matters: If sector revenue growth speeds up, it could help Cross Country Healthcare. This would improve market conditions.
Confirms:Sector revenue growth is speeding up again. This shows that demand is getting stronger.
Disproves:Sector revenue growth is still slowing down. This means there are ongoing challenges.
Entry Into a Material Definitive Agreement. Agreement and Plan of Merger On May 6, 2026, Cross Country Healthcare, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among the Company, KL Criss Cross Intermediate, LLC, a Delaware limited liability company (“ Parent ”), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), pursuant to which Merger Sub wil…
Other Events In consideration of the proposed Merger, the Company is canceling its earnings conference call to discuss its first quarter 2026 financial results, which was previously scheduled to be held on May 7, 2026. Additionally, the Board has determined to cancel the Company’s 2026 Annual Meeting of Stockholders (the “ 2026 Annual Meeting ”), which was previously scheduled to be held virtually on May 11, 2026, and to withdraw from consideration by the Company’s stockholders the proposals…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 25, 2026, the Board of Directors of Cross Country Healthcare, Inc. (the “Company”) approved the appointment of Amiee Hawkins as Chief Operating Officer of the Company, effective as of March 28, 2026 (the “Appointment”). Prior to the Appointment, Ms. Hawkins was serving as the Company’s Chief Solutions and Operations Officer. Ms. Hawkins, 4…
Results of Operations and Financial Condition (a) On March 4, 2026, Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the fourth quarter and full year ended December 31, 2025, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished under